Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
J Clin Invest ; 121(1): 328-41, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21183788

ABSTRACT

Sex in mammals is genetically determined and is defined at the cellular level by sex chromosome complement (XY males and XX females). The Y chromosome-linked gene sex-determining region Y (SRY) is believed to be the master initiator of male sex determination in almost all eutherian and metatherian mammals, functioning to upregulate expression of its direct target gene Sry-related HMG box-containing gene 9 (SOX9). Data suggest that SRY evolved from SOX3, although there is no direct functional evidence to support this hypothesis. Indeed, loss-of-function mutations in SOX3 do not affect sex determination in mice or humans. To further investigate Sox3 function in vivo, we generated transgenic mice overexpressing Sox3. Here, we report that in one of these transgenic lines, Sox3 was ectopically expressed in the bipotential gonad and that this led to frequent complete XX male sex reversal. Further analysis indicated that Sox3 induced testis differentiation in this particular line of mice by upregulating expression of Sox9 via a similar mechanism to Sry. Importantly, we also identified genomic rearrangements within the SOX3 regulatory region in three patients with XX male sex reversal. Together, these data suggest that SOX3 and SRY are functionally interchangeable in sex determination and support the notion that SRY evolved from SOX3 via a regulatory mutation that led to its de novo expression in the early gonad.


Subject(s)
46, XX Testicular Disorders of Sex Development/genetics , SOXB1 Transcription Factors/genetics , 46, XX Testicular Disorders of Sex Development/metabolism , 46, XX Testicular Disorders of Sex Development/pathology , Adult , Aldehyde Dehydrogenase/genetics , Aldehyde Dehydrogenase 1 Family , Animals , Base Sequence , DNA Primers/genetics , Disease Models, Animal , Female , Gene Expression Regulation, Developmental , Gene Rearrangement , Humans , Infant , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Pregnancy , Regulatory Sequences, Nucleic Acid , Retinal Dehydrogenase , SOX9 Transcription Factor/genetics , Sertoli Cells/metabolism , Sertoli Cells/pathology , Testis/embryology , Testis/pathology , Up-Regulation
3.
Nat Genet ; 40(6): 776-81, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18469813

ABSTRACT

Epilepsy and mental retardation limited to females (EFMR) is a disorder with an X-linked mode of inheritance and an unusual expression pattern. Disorders arising from mutations on the X chromosome are typically characterized by affected males and unaffected carrier females. In contrast, EFMR spares transmitting males and affects only carrier females. Aided by systematic resequencing of 737 X chromosome genes, we identified different protocadherin 19 (PCDH19) gene mutations in seven families with EFMR. Five mutations resulted in the introduction of a premature termination codon. Study of two of these demonstrated nonsense-mediated decay of PCDH19 mRNA. The two missense mutations were predicted to affect adhesiveness of PCDH19 through impaired calcium binding. PCDH19 is expressed in developing brains of human and mouse and is the first member of the cadherin superfamily to be directly implicated in epilepsy or mental retardation.


Subject(s)
Cadherins/genetics , Chromosomes, Human, X , Codon, Nonsense/genetics , Cognition Disorders/genetics , Epilepsy/genetics , Genomic Imprinting , Mutation, Missense/genetics , Animals , Brain/growth & development , Brain/metabolism , Brain/pathology , Case-Control Studies , Cognition Disorders/pathology , Epilepsy/pathology , Female , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Regulation, Developmental , Genes, X-Linked/genetics , Humans , In Situ Hybridization , Male , Mental Retardation, X-Linked/genetics , Mental Retardation, X-Linked/pathology , Mice/embryology , Pedigree , Phenotype , Protocadherins , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Skin/cytology , Skin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL